An increase in tumor marker levels, such as those of cancer antigen 125 and SCC or squamous cell carcinoma antigen, is commonly associated with disease recurrence and therefore follow-up should be initiated [113,120,121]. The gene discussed is MUC16; the disease is neoplasm.